⌂
Home
◈
Markets
▦
Screener
📈
Tools
◎
Portfolio
Skip to content
DFM General
5,734.19
−1.44%
FTSE ADX
9,588.41
−1.17%
TASI
9,695.86
−2.32%
QE Index
8,611.10
−0.37%
S&P 500
7,644.32
−0.25%
Nasdaq 100
29,089.56
+0.45%
Nifty 50
22,600.00
−0.39%
Sensex
73,123.83
−0.17%
KSE-100
162,374.88
−0.95%
DFM:EMIRATESNBD
AED 30.00
−3.47%
ADX:IHC
AED 350.00
−0.57%
SAU:2222
SAR 25.40
−0.70%
DSMD:QNBK
QAR 15.50
−1.02%
NAS:NVDA
$213.03
+0.39%
NYSE:TSM
$420.15
+1.89%
NSE:RELIANCE
₹1,190.00
+0.46%
KAR:OGDC
Rs 298.12
−0.79%
Gold
$4,002.03
−0.56%
Brent
$116.03
+2.78%
BTC
$81,680.95
+0.45%
ETH
$2,406.00
+0.83%
DFM General
5,734.19
−1.44%
FTSE ADX
9,588.41
−1.17%
TASI
9,695.86
−2.32%
QE Index
8,611.10
−0.37%
S&P 500
7,644.32
−0.25%
Nasdaq 100
29,089.56
+0.45%
Nifty 50
22,600.00
−0.39%
Sensex
73,123.83
−0.17%
KSE-100
162,374.88
−0.95%
DFM:EMIRATESNBD
AED 30.00
−3.47%
ADX:IHC
AED 350.00
−0.57%
SAU:2222
SAR 25.40
−0.70%
DSMD:QNBK
QAR 15.50
−1.02%
NAS:NVDA
$213.03
+0.39%
NYSE:TSM
$420.15
+1.89%
NSE:RELIANCE
₹1,190.00
+0.46%
KAR:OGDC
Rs 298.12
−0.79%
Gold
$4,002.03
−0.56%
Brent
$116.03
+2.78%
BTC
$81,680.95
+0.45%
ETH
$2,406.00
+0.83%
☰
Markets
▼
Stock markets
🇦🇪
UAE
DFM · ADX · DFM General
Closed
🇸🇦
Saudi Arabia
Tadawul · TASI
Closed
🇶🇦
Qatar
QSE · QE General
Closed
🇺🇸
United States
Nasdaq · NYSE · S&P 500
Open
🇮🇳
India
NSE · BSE · Nifty 50
Closed
🇵🇰
Pakistan
PSX · KSE-100
Closed
Other assets
₿
Crypto
Ranked by volume · 24/7
🥇
Gold, FX & economy
Dubai gold, AED crosses, rates
◫
ETFs
Index, sector and gold funds
Explore
▦
Market map
Every market as a heatmap
📅
Calendar & IPOs
Earnings, dividends, listings, releases
⌁
Options flow · Ownership · Politics
US filings and tapes
Screener
▼
⚲
Stock screener
All six markets, one row per company
★
Ready-made screens
Starting points with a point of view
📁
My saved screens
Saved rules with alerts on new matches
⇄
Compare
Up to five, side by side
Crypto
Tools
▼
📈
Charting
Drawings, indicators, replay
▶
Strategy Maker
Write a rule, test it on history
⇄
Compare
Side by side
🔔
Alerts
Price, earnings, screens, strategies
News
Portfolio
⌕
AED
USD
SAR
QAR
INR
PKR
GBP
EUR
KWD
OMR
BHD
☆
♢
☾
Sign in
Create account
👤
Markets
›
United States
› NAS
› SGMT
S
Sagimet Biosciences Inc
NAS:SGMT
Healthcare
CBOEFTSE:MRUT
NASDAQ:NBI
$9.70
−2.51%
Live
In session · ≈
AED 35.62
· Market cap
$682.31M
· Next earnings
Thu 12 Nov
☆
Watch
🔔
Alert
⇄
Compare
▶
Test a strategy
✦
AI read
Overview
Chart
Financials
Valuation
Forecasts
Dividends
Ownership
Options
Shorts
News
Profile
Sagimet Biosciences Inc · News · TradingHolo
SGMT news
Headlines tagged to this company
TR
Sagimet Biosciences Updates Pipeline: Acne Phase 3 Underway, TVB-3567 Phase 2 Planned
TradingView · 28 h ago
GL
Sagimet To Present Positive Full 52-Week Results from License Partner Ascletis' Phase 3 Open-Label Extension Clinical Trial of Denifanstat in Acne and Mechanistic Data at the 2026 Fall Clinical Dermatology Conference
GlobeNewswire · 14 d ago
DO
Sagimet Biosciences Price Target Maintained With a $29.00/Share by HC Wainwright & Co.
Dow Jones Newswires · 18 d ago
TR
HC Wainwright & Co. reiterates Buy rating on Sagimet Biosciences, $29 price target
TradingView · 18 d ago
DO
Sagimet Biosciences Price Target Raised to $26.00/Share From $25.00 by Guggenheim
Dow Jones Newswires · 21 d ago
TR
Guggenheim maintains Buy rating on Sagimet Biosciences, $26 price target
TradingView · 21 d ago
SE
Sagimet closes down after acne drug denifanstat data, closing of stock offering
Seeking Alpha · 22 d ago
TR
Sagimet Biosciences Inc. (SGMT) Closes $115M Stock and Pre-Funded Warrant Offering
TradingView · 22 d ago
DO
Sagimet Biosciences Price Target Raised to $38.00/Share From $33.00 by Oppenheimer
Dow Jones Newswires · 22 d ago
TR
Oppenheimer maintains Outperform rating on Sagimet Biosciences, $38 price target
TradingView · 22 d ago
DO
Sagimet Biosciences Is Maintained at Market Outperform by Citizens
Dow Jones Newswires · 22 d ago
TR
Citizens maintains Market Outperform rating on Sagimet Biosciences, $27 price target
TradingView · 22 d ago
TR
Sagimet Biosciences Raises $107.5 Million in Underwritten Offering Led by Leerink, TD, Guggenheim
TradingView · 22 d ago
QU
SGMT: Denifanstat achieved rapid, durable efficacy and strong safety in moderate to severe acne over 52 weeks
Quartr · 23 d ago
QU
SGMT: Denifanstat achieved rapid, durable efficacy and strong safety in moderate to severe acne, supporting first-line use
Quartr · 23 d ago
ST
Sagimet Raises $115M At Premium To Fund Phase 3 Acne Drug Trial – SGMT Stock Surges Pre-Market
Stocktwits · 23 d ago
SE
Sagimet Biosciences stock rises after pricing $115M securities offering
Seeking Alpha · 23 d ago
RE
Sagimet Biosciences Announces Pricing Of $115.0 Million Underwritten Offering Of Series A Common Stock And Pre-Funded Warrants
Reuters · 23 d ago
GL
Sagimet Biosciences Announces Pricing of $115.0 Million Underwritten Offering of Series A Common Stock and Pre-Funded Warrants
GlobeNewswire · 23 d ago
RE
Sagimet Biosciences - Suspends And Terminates ATM Prospectus Supplement For Series A Common Stock Effective Sept 30
Reuters · 23 d ago
More news →